AU2954692A - Medical preparations - Google Patents

Medical preparations

Info

Publication number
AU2954692A
AU2954692A AU29546/92A AU2954692A AU2954692A AU 2954692 A AU2954692 A AU 2954692A AU 29546/92 A AU29546/92 A AU 29546/92A AU 2954692 A AU2954692 A AU 2954692A AU 2954692 A AU2954692 A AU 2954692A
Authority
AU
Australia
Prior art keywords
medical preparations
preparations
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29546/92A
Inventor
Paul Douglas Clarke
Bruce Darren Forrest
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MASTAVAC Ltd
Original Assignee
MASTAVAC Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MASTAVAC Ltd filed Critical MASTAVAC Ltd
Publication of AU2954692A publication Critical patent/AU2954692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU29546/92A 1991-12-03 1992-12-03 Medical preparations Abandoned AU2954692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9125695 1991-12-03
GB919125695A GB9125695D0 (en) 1991-12-03 1991-12-03 Medical preparations

Publications (1)

Publication Number Publication Date
AU2954692A true AU2954692A (en) 1993-06-28

Family

ID=10705619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29546/92A Abandoned AU2954692A (en) 1991-12-03 1992-12-03 Medical preparations

Country Status (3)

Country Link
AU (1) AU2954692A (en)
GB (1) GB9125695D0 (en)
WO (1) WO1993011220A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
JPH10508744A (en) 1994-09-22 1998-09-02 クオドラント ホールディングス ケンブリッジ リミテッド Compositions for hydration and nutritional use during athletics and methods of making the same
US6964771B1 (en) 1995-06-07 2005-11-15 Elan Drug Delivery Limited Method for stably incorporating substances within dry, foamed glass matrices
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
DE69735600T2 (en) * 1997-11-26 2007-01-25 Universal Preservation Technologies, Inc., San Diego PRESERVING DELICATE BIOLOGICAL SAMPLES THROUGH GLAZING
DK1175486T3 (en) * 1999-05-04 2007-10-29 Anhydro Ltd Method of preserving virus and mycoplasm
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
US7045149B2 (en) 1999-09-08 2006-05-16 Cornell Research Foundation, Inc. Ruminal fluid inoculation of calves
WO2002067692A1 (en) * 2001-02-21 2002-09-06 Cornell Research Foundation, Inc. Ruminal fluid inoculation of calves
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1670505B1 (en) 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines
US8011132B2 (en) * 2004-12-23 2011-09-06 Becker Underwood Inc. Enhanced shelf life and on seed stabilization of liquid bacterium inoculants
DE102006033098A1 (en) * 2006-07-14 2008-01-24 Rebholz, Erich, Dr. Method and device for temporary storage of microbes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1443392A (en) * 1974-02-20 1976-07-21 Grace W R & Co Ruminant feed additive
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DD299213A7 (en) * 1988-05-04 1992-04-09 Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De METHOD FOR STABILIZING A LIVE VIRUS VACCINE AGAINST TEMPERATURE EFFECT
US5695541A (en) * 1990-11-13 1997-12-09 Liphatech, Inc. Process for preparation of bacterial agricultural products

Also Published As

Publication number Publication date
WO1993011220A1 (en) 1993-06-10
GB9125695D0 (en) 1992-01-29

Similar Documents

Publication Publication Date Title
AU654030B2 (en) Skin whitening preparations
AU7338791A (en) Medical valve
AU1219292A (en) Inhaler
AU2263692A (en) Multiple pharmaceutical syringe
AU3802493A (en) Surgical endoclip
AU8557591A (en) Medical device
AU2470792A (en) Wheelchair
AU3888793A (en) Novel medicament
AU2421192A (en) Inhaler
AU2186792A (en) Patient sling
AU3099992A (en) Medical environment interface
AU8737091A (en) Wheelchair
AU2954692A (en) Medical preparations
AU9128891A (en) Single use syringe
AU2838192A (en) Catheter
AU3950193A (en) Cannula
AU8072691A (en) Pharmaceutical preparations
AU4219793A (en) Syringe
AU4014193A (en) Chair
AU649061B2 (en) Single use syringe
AU5737494A (en) Human thrombospondin-4
AU2493792A (en) Pharmaceutical preparation
AU5112193A (en) Chair
AU5050490A (en) Human monocyte-macrophage-csf preparations
AU1740692A (en) New medicinal use